Breast-feeding infants whose mothers are on anti-epileptic drug monotherapy do not appear to have an increased risk of cognitive impairment at age 2, according to research presented this week at the annual meeting of the American Academy of Neurology in Chicago.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.